Smith Michael Alexander's Form 4 filing
INSMED Inc (INSM) · filed Jul 15, 2025
- Accession no.
- 0001104506-25-000029
- Filed
- Jul 15, 2025
- Trade date
- Jul 11-15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $167.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Michael AlexanderCIK 0001870278 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | Common Stock | SSaleDisposed | −748 | $96.41 | −$72,114.68 | 67,327 | Direct | |
| Jul 15, 2025 | Common Stock | SSaleDisposed | −933 | $102.51F4 | −$95,641.83 | 66,394 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This is the weighted average sales price representing 933 shares sold at prices ranging from $102.37 to $102.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.